Literature DB >> 15516957

Friends or foes - bipolar effects of the tumour stroma in cancer.

Margareta M Mueller1, Norbert E Fusenig.   

Abstract

The restricted view of tumour progression as a multistep process defined by the accumulation of mutations in cancer cells has largely ignored the substantial contribution of the tumour microenvironment to malignancy. Even though the seed and soil hypothesis of Paget dates to 1889, it has been less than two decades since researchers have included the tumour microenvironment in their analyses of tumour progression. What have we recently learned from studying tumour-stroma interactions, and will this help to define new targets for therapy?

Entities:  

Mesh:

Year:  2004        PMID: 15516957     DOI: 10.1038/nrc1477

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  664 in total

1.  S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment.

Authors:  Hilde Ljones Wetting; Elin Hadler-Olsen; Synnøve Magnussen; Oddveig Rikardsen; Sonja E Steigen; Elisabeth Sundkvist; Thrina Loennechen; Premasany Kanapathippillai; Hanne Kildalsen; Jan-Olof Winberg; Lars Uhlin-Hansen; Gunbjørg Svineng
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression.

Authors:  J Melo-Cardenas; M Urquiza; T J Kipps; J E Castro
Journal:  Cancer Gene Ther       Date:  2012-03-09       Impact factor: 5.987

3.  T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer.

Authors:  Ewelina Kluza; Esther D Rozeboom; Monique Maas; Milou Martens; Doenja M J Lambregts; Jos Slenter; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

4.  Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.

Authors:  Xiuying Li; Yongsheng Wang; Yuwei Zhao; Hengxiu Yang; Aiping Tong; Chengjian Zhao; Huashan Shi; Yang Li; Zhenlin Wang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

Review 5.  Design and development of therapies using chimeric antigen receptor-expressing T cells.

Authors:  Gianpietro Dotti; Stephen Gottschalk; Barbara Savoldo; Malcolm K Brenner
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

Authors:  Federica Sotgia; Francesco Del Galdo; Mathew C Casimiro; Gloria Bonuccelli; Isabelle Mercier; Diana Whitaker-Menezes; Kristin M Daumer; Jie Zhou; Chenguang Wang; Sanjay Katiyar; Huan Xu; Emily Bosco; Andrew A Quong; Bruce Aronow; Agnieszka K Witkiewicz; Carlo Minetti; Philippe G Frank; Sergio A Jimenez; Erik S Knudsen; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

7.  Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.

Authors:  Ake Oldberg; Sebastian Kalamajski; Alexei V Salnikov; Linda Stuhr; Matthias Mörgelin; Rolf K Reed; Nils-Erik Heldin; Kristofer Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

8.  Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

Authors:  Maud Jost; Catherine Maillard; Julie Lecomte; Vincent Lambert; Marc Tjwa; Pierre Blaise; Maria-Luz Alvarez Gonzalez; Khalid Bajou; Silvia Blacher; Patrick Motte; Chantal Humblet; Marie Paule Defresne; Marc Thiry; Francis Frankenne; André Gothot; Peter Carmeliet; Jean-Marie Rakic; Jean-Michel Foidart; Agnès Noël
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

9.  Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.

Authors:  Samuel Kim; George Buchlis; Zvi G Fridlender; Jing Sun; Veena Kapoor; Guanjun Cheng; Andrew Haas; Hung Kam Cheung; Xiamei Zhang; Michael Corbley; Larry R Kaiser; Leona Ling; Steven M Albelda
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

10.  Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Damanzoopinder Samrao; Grace Kim; Kate Lawrenson; Teodulo Meneses; Song Liu; Annie Yessaian; Tanja Pejovic
Journal:  Cancer Microenviron       Date:  2013-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.